July 08, 2025

EVOO, Petrolatum Both Improve Skin Barrier Metrics

A clinical trial in healthy adults found that both extra virgin olive oil and petrolatum significantly improved skin hydration and barrier function, with differing effects on water loss and skin cell turnover.

Conexiant

July 03, 2025

Is Skin Thicker with Vitamin C?

Vitamin C may help thicken human skin by epigenetically activating genes involved in cell growth, according to new research using a lab-grown human skin model. The study found that vitamin C, or L-ascorbic acid, promotes epidermal proliferation by modifying gene activity through DNA demethylation.

Conexiant

July 03, 2025

Sonelokimab, Biologics Show Benefit in Hidradenitis Suppurativa

A systematic review and network meta-analysis of clinical trials found that several biologic and small-molecule therapies provided short-term improvement in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

July 02, 2025

Medical Oddities: Leprosy’s Old New World Secret

This week’s clinical grab bag: tea for gloom, ancient leprosy, smoggy fibrosis & power peeing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Could Age Predict DVT in Cellulitis?

A 10-year study found that individuals aged 70 and above with lower limb cellulitis had significantly higher odds of developing deep vein thrombosis.

Conexiant

June 27, 2025

Herbal Emollient Shows Lasting Relief for Eczema

Clinical trial finds herbal emollients with ginger and cannabidiol reduce itch, improve symptoms, and restore skin barrier in mild atopic dermatitis.

Conexiant

June 26, 2025

First Targeted Therapy Approved for BP

The FDA has approved dupilumab as the first targeted treatment for adults with bullous pemphigoid, showing improved remission rates and reduced corticosteroid use.

Conexiant